Overview
- 12 inspections across 12 sites are on record.
- 24 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-03-20.
At a glance
Inspections
12
Sites
12
Observations
24
Career since
Jan 2024
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Omega & Delta Co., Inc. | 20 Mar 2026 | Human Drugs | View 483 → |
| Ingenus Pharmaceuticals NJ, LLC. | 9 Jan 2026 | Human Drugs | |
| Indiana Botanic Gardens, Inc | 30 Sep 2025 | Human Drugs | View 483 → |
| Dee Cee Laboratories, Inc | 11 Aug 2025 | Human Drugs | View 483 → |
| Osmotica Pharmaceutical US LLC | 2 May 2025 | Human Drugs | View 483 → |
Sites inspected
Omega & Delta Co., Inc.Carolina, United States1 insp.
Ingenus Pharmaceuticals NJ, LLC.Fairfield, United States1 insp.
Indiana Botanic Gardens, IncHobart, United States1 insp.
Dee Cee Laboratories, IncWhite House, United States1 insp.
Osmotica Pharmaceutical US LLCMarietta, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Tanya R Syffrard2 shared
Veronica Fuentes2 shared
Alisha B Patel1 shared
Nelson N Ayangho1 shared
Andrew O Ejiofor1 shared
Samantha E Cleek1 shared
Inga M Warr1 shared
Anthony J Donato1 shared
JoshRenzo N Ramilo1 shared
Pamela N Agaba1 shared
Full investigator report
Get the verbatim findings behind Tomika L Crafter's 24 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site